Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th
JERSEY, Channel Islands, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2022 will be released before market open on Tuesday, August 9, 2022.
| Title: | Quotient First Quarter Fiscal 2023 Financial Results and Conference Call | |
| Speakers: | Manuel O. Méndez, Chief Executive Officer Ali J. Kiboro, Chief Financial Officer | |
| Date: | Tuesday, August 9, 2022 | |
| Time: | 8:30am ET/ 14:30 CET | |
| Conference Call Dial-in Details: | International: 201-689-8560 Switzerland: 0800 835 525 United Kingdom: 0800 756 3429 US: 877-407-0784 Conference ID: 13731396 | |
| Webcast: | Webcast Link - Click Here Quotient Events & Presentations | |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company's website.
About Quotient Limited
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. The MosaiQ solution, Quotient's proprietary multiplex microarray technology, offers the world's first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. The MosaiQ solution is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, and deliver significant workflow improvements and operational cost savings to laboratories around the world. Quotient's operations are based in Switzerland, Scotland, US, and the UAE.
The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.
CONTACT: Investor Relations, [email protected]; +41 22 545 52 26
